Abstract
Glioma is known as one of the most common primary intracranial tumors accounting for four-fifths of malignant brain tumors. There are several biological pathways that play a synergistic, pathophysiological role in glioma, including apoptosis, autophagy, oxidative stress, and cell cycle arrest. According to previous rese arches, the drugs used in the treatment of glioma have been associated with significant limitations. Therefore, improved and/or new therapeutic platforms are required. In this regard, multiple flavonoids and alkaloids have been extensively studied in the treatment of glioma. Berberine is a protoberberine alkaloid with wide range of pharmacological activities, applicable to various pathological conditions. Few studies have reported beneficial roles of berberine in glioma. Berberine exerts its pharmacological functions in glioma by controlling different molecular and cellular pathways. We reviewed the existing knowledge supporting the use of berberine in the treatment of glioma and its effects on molecular and cellular mechanisms.
Similar content being viewed by others
References
Annovazzi L, Mellai M, Caldera V, Valente G, Tessitore L, Schiffer D (2009) mTOR, S6 and AKT expression in relation to proliferation and apoptosis/autophagy in glioma. Anticancer Res 29(8):3087–3094
Ashkenazi A (2008) Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev 19(3–4):325–331
Badiga AV, Chetty C, Kesanakurti D, Are D, Gujrati M, Klopfenstein JD, Dinh DH, Rao JS (2011) MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS ONE 6(6):e20614
Balmanno K, Cook S (2009) Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16(3):368
Besson A, Davy A, Robbins SM, Yong VW (2001) Differential activation of ERKs to focal adhesions by PKC ε is required for PMA-induced adhesion and migration of human glioma cells. Oncogene 20(50):7398
Bhutada P, Mundhada Y, Bansod K, Dixit P, Umathe S, Mundhada D (2010) Anticonvulsant activity of berberine, an isoquinoline alkaloid in mice. Epilepsy Behav 18(3):207–210
Butcher NJ, Minchin RF (2012) Arylamine N-acetyltransferase 1: a novel drug target in cancer development. Pharmacol Rev 64(1):147–165
Chen D-b, Davis JS (2003) Epidermal growth factor induces c-fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and-independent pathways in bovine luteal cells. Mol Cell Endocrinol 200(1–2):141–154
Chen K, Hao D, Liu Z, Chen Y, You Z (1994) Effect of berberine alone or in combination with argon ion laser treatment on 9L rat glioma cell line. Chin Med J 107(11):808–812
Chen T-C, Lai K-C, Yang J-S, Liao C-L, Hsia T-C, Chen G-W, Lin J-J, Lin H-J, Chiu T-H, Tang Y-J (2009) Involvement of reactive oxygen species and caspase-dependent pathway in berberine-induced cell cycle arrest and apoptosis in C6 rat glioma cells. Int J Oncol 34(6):1681–1690
Cholia RP, Dhiman M, Kumar R, Mantha AK (2018) Oxidative stress stimulates invasive potential in rat C6 and human U-87 MG glioblastoma cells via activation and cross-talk between PKM2, ENPP2 and APE1 enzymes. Metab Brain Dis 33(4):1307–1326
Chung J, Wu L, Chu C, Jan J, Ho C, Tsou M, Lu H, Chen G, Lin J, Wang T (1999) Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells. Food Chem Toxicol 37(4):319–326
da Silva AB, Coelho PLC, das Neves Oliveira M, Oliveira JL, Amparo JAO, da Silva KC, Soares JRP, Pitanga BPS, dos Santos Souza C, de Faria Lopes GP (2019) The flavonoid rutin and its aglycone quercetin modulate the microglia inflammatory profile improving antiglioma activity. Brain Behav Immun 85:170–185
De Luca A, Maiello MR, D'Alessio A, Pergameno M, Normanno N (2012) The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 16(sup2):S17–S27
Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104(6):1129–1137
Dong C, Davis RJ, Flavell RA (2002) MAP kinases in the immune response. Annu Rev Immunol 20(1):55–72
Durairajan SSK, Liu L-F, Lu J-H, Chen L-L, Yuan Q, Chung SK, Huang L, Li X-S, Huang J-D, Li M (2012) Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Neurobiol Aging 33(12):2903–2919
Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161
Eom K-S, Hong J-M, Youn M-J, So H-S, Park R, Kim J-M, Kim T-Y (2008) Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. Biol Pharm Bull 31(4):558–562
Eom KS, Kim H-J, So H-S, Park R, Kim TY (2010) Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction. Biol Pharm Bull 33(10):1644–1649
Fan Q-W, Weiss WA (2011) Autophagy and Akt promote survival in glioma. Autophagy 7(5):536–538
Filippi-Chiela EC, Villodre ES, Zamin LL, Lenz G (2011) Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS ONE 6(6):e20849
Forsyth P, Wong H, Laing TD, Rewcastle N, Morris D, Muzik H, Leco K, Johnston R, Brasher P, Sutherland G (1999) Gelatinase-A (MMP-2) gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79(11):1828
Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H (1999) Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66(2):227–233
Fulda S, Debatin K-M (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25(34):4798
Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ (2009) Apoptosis and cancer: mutations within caspase genes. J Med Genet 46(8):497–510
Guo Y, Hong W, Wang X, Zhang P, Körner H, Tu J, Wei W (2019) MicroRNAs in microglia: How do MicroRNAs affect activation, inflammation, polarization of microglia and mediate the interaction between microglia and glioma? Front Mol Neurosci 12:125
Howlader N (2011) SEER cancer statistics review, 1975–2008. http://seercancergov/csr/1975_2008/
Jacques-Silva MC, Bernardi A, Rodnight R, Lenz G (2004) ERK, PKC and PI3K/Akt pathways mediate extracellular ATP and adenosine-induced proliferation of U138-MG human glioma cell line. Oncology 67(5–6):450–459
Kabir S, Rehman A (2018) Carcinogenic potential of arylamine N-acetyltransferase in Asian populations: A review. J Cancer Res Pract 5:131–135
Kan LK, Williams D, Drummond K, O'Brien T, Monif M (2019) The role of microglia and P2X7 receptors in gliomas. J Neuroimmunol 332:138–146
Kang R, Zeh H, Lotze M, Tang D (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18(4):571
Kim H-S, Lee W, Lee S, Chae H-W, Kim D, Oh Y (2010) Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Horm Metab Res 42(03):165–172
Kim M, Cho K-H, Shin M-S, Lee J-M, Cho H-S, Kim C-J, Shin D-H, Yang HJ (2014) Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. Int J Mol Med 33(4):870–878
Kim S, Choi JH, Kim JB, Nam SJ, Yang J-H, Kim J-H, Lee JE (2008) Berberine suppresses TNF-α-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 13(12):2975–2985
Kim S, Han J, Lee SK, Choi M-Y, Kim J, Lee J, Jung SP, Kim JS, Kim J-H, Choe J-H (2012) Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells. J Surg Res 176(1):e21–e29
Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5(9):726
Laperriere N, Zuraw L, Cairncross G, Group CCOPGIN-ODS (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64(3):259–273
Lee WC, Choi CH, Cha SH, Oh HL, Kim YK (2005) Role of ERK in hydrogen peroxide-induced cell death of human glioma cells. Neurochem Res 30(2):263–270
Leist M, Volbracht C, Kühnle S, Fava E, Ferrando-May E, Nicotera P (1997) Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol Med 3(11):750
Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W (2012) Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149(6):1269–1283
Lin C-C, Kao S-T, Chen G-W, Chung J-G (2005) Berberine decreased N-acetylation of 2-aminofluorene through inhibition of N-acetyltransferase gene expression in human leukemia HL-60 cells. Anticancer Res 25(6B):4149–4155
Lin J-P, Yang J-S, Lee J-H, Hsieh W-T, Chung J-G (2006) Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol: WJG 12(1):21
Lin J-P, Yang J-S, Wu C-C, Lin S-S, Hsieh W-T, Lin M-L, Yu F-S, Yu C-S, Chen G-W, Chang Y-H (2008a) Berberine induced down-regulation of matrix metalloproteinase-1,-2 and-9 in human gastric cancer cells (SNU-5) in vitro. In Vivo 22(2):223–230
Lin T-H, Kuo H-C, Chou F-P, Lu F-J (2008b) Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 8(1):58
Liu Q, Jiang H, Liu Z, Wang Y, Zhao M, Hao C, Feng S, Guo H, Xu B, Yang Q (2011) Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS ONE 6(8):e23427
Liu Q, Xu X, Zhao M, Wei Z, Li X, Zhang X, Liu Z, Gong Y, Shao C (2015) Berberine induces senescence of human glioblastoma cells by downregulating the EGFR–MEK–ERK signaling pathway. Mol Cancer Ther 14(2):355–363
Luo S, Lei K, Xiang D, Ye K (2018) NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress. Oxidat Med Cell Longev 201:9146528–9146528
Mantena SK, Sharma SD, Katiyar SK (2006) Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5(2):296–308
Marconi GD, Gallorini M, Carradori S, Guglielmi P, Cataldi A, Zara S (2019) The Up-Regulation of Oxidative Stress as a Potential Mechanism of Novel MAO-B Inhibitors for Glioblastoma Treatment. Molecules 24(10):2005
Masoudi MS, Mehrabian E, Mirzaei H (2018) MiR-21: A key player in glioblastoma pathogenesis. J Cell Biochem 119(2):1285–1290
Meier F, Schittek B, Busch S, Garbe C, Smalley K, Satyamoorthy K, Li G, Herlyn M (2005) The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci 10(2986–3001):2986–3001
Mizushima N (2007) Autophagy: process and function. Genes Dev 21(22):2861–2873
Mooney J, Bernstock JD, Ilyas A, Ibrahim A, Yamashita D, Markert JM, Nakano I (2019) Current approaches and challenges in the molecular therapeutic targeting of glioblastoma. World Neurosurg
Nyormoi O, Mills L, Bar-Eli M (2003) An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death Differ 10(5):558
Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro-oncology 19(suppl_5):1–88
Palumbo S, Pirtoli L, Tini P, Cevenini G, Calderaro F, Toscano M, Miracco C, Comincini S (2012) Different involvement of autophagy in human malignant glioma cell lines undergoing irradiation and temozolomide combined treatments. J Cell Biochem 113(7):2308–2318
Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246(4930):603–608
Pece S, Gutkind JS (2000) Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem 275(52):41227–41233
Peng P-l, Kuo W-H, Tseng H-C, Chou F-P (2008) Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 70(2):529–542
Picart T, Berhouma M, Dumot C, Pallud J, Metellus P, Armoiry X, Guyotat J (2019) Optimization of high-grade glioma resection using 5-Ala fluorescence-guided surgery: literature review and practical recommendations from the Neuro-Oncology Club Of The French Society Of Neurosurgery. Neurochirurgie 65:164–177
Russell RC, Tian Y, Yuan H, Park HW, Chang Y-Y, Kim J, Kim H, Neufeld TP, Dillin A, Guan K-L (2013) ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 15(7):741
Saadatpour L, Fadaee E, Fadaei S, Mansour RN, Mohammadi M, Mousavi S, Goodarzi M, Verdi J, Mirzaei H (2016) Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther 23(12):415
Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanam S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS (1996) Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metas 14(1):35–42
Schild L, Chen B, Makarov P, Kattengell K, Heinitz K, Keilhoff G (2010) Selective induction of apoptosis in glioma tumour cells by a Gynostemma pentaphyllum extract. Phytomedicine 17(8–9):589–597
See WL, Mukherjee J (2018) Targeting the RAS-RAF-MEK-ERK signaling pathway in gliomas. In: Newton HB (ed) Handbook of brain tumor chemotherapy, molecular therapeutics, and immunotherapy. Elsevier, New York, pp 323–332
Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12(11):997–1003
Sim E, Abuhammad A, Ryan A (2014) Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. Br J Pharmacol 171(11):2705–2725
Song JH, Song DK, Pyrzynska B, Petruk KC, Van Meir EG, Hao C (2003) TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathol 13(4):539–553
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466
Sun Y, Yu J, Liu X, Zhang C, Cao J, Li G, Liu X, Chen Y, Huang H (2018) Oncosis-like cell death is induced by berberine through ERK1/2-mediated impairment of mitochondrial aerobic respiration in gliomas. Biomed Pharmacother 102:699–710
Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78(4):703–711
Thorns V, Walter G, Thorns C (2003) Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23(5A):3937–3944
Tian C, Asghar S, Hu Z, Qiu Y, Zhang J, Shao F, Xiao Y (2019) Understanding the cellular uptake and biodistribution of a dual-targeting carrier based on redox-sensitive hyaluronic acid-ss-curcumin micelles for treating brain glioma. Int J Biol Macromol 136:143–153
Tong L, Xie C, Wei Y, Qu Y, Liang H, Zhang Y, Xu T, Qian X, Qiu H, Deng H (2019) Antitumor effects of berberine on gliomas via inactivation of caspase-1-mediated IL-1β and IL-18 release. Front Oncol 9:364
Ulasov I, Thaci B, Sarvaiya P, Yi R, Guo D, Auffinger B, Pytel P, Zhang L, Kim CK, Borovjagin A (2013) Inhibition of MMP 14 potentiates the therapeutic effect of temozolomide and radiation in gliomas. Cancer Med 2(4):457–467
Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303(23):1323–1329
Wang D, Yeh C, Lee J, Hung C, Chung J (2002) Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells. Neurochem Res 27(9):883–889
Wang J, Qi Q, Feng Z, Zhang X, Huang B, Chen A, Prestegarden L, Li X, Wang J (2016) Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway. Oncotarget 7(41):66944
Wang N, Feng Y, Zhu M, Tsang CM, Man K, Tong Y, Tsao SW (2010) Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 111(6):1426–1436
Windmill KF, Gaedigk A, de la M, Hall P, Samaratunga H, Grant DM, McManus ME (2000) Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci 54(1):19–29
Wong RS (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30(1):87
Wu C-C, Bratton SB (2013) Regulation of the intrinsic apoptosis pathway by reactive oxygen species. Antioxid Redox Signal 19(6):546–558
Wu H, Fu X, Cao W, Xiang W, Hou Y, Ma J, Wang Y, Fan C (2019) Induction of apoptosis in human glioma cells by fucoxanthin via triggering of ROS-mediated oxidative damage and regulation of MAPKs and PI3K-AKT pathways. J Agric Food Chem 67(8):2212
Wu Y-T, Tan H-L, Huang Q, Ong C-N, Shen H-M (2009) Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy. Autophagy 5(6):824–834
Yount G, Qian Y, Moore D, Basila D, West J, Aldape K, Arvold N, Shalev N, Haas-Kogan D (2004) Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro. J Exp Ther Oncol 4(2):137–143
Yu R, Zhang Z-q, Wang B, Jiang H-x, Cheng L, Shen L-m (2014) Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation. Cancer Cell Int 14(1):49
Zou Y, Wang Q, Li B, Xie B, Wang W (2014) Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma. Mol Med Rep 10(1):411–416
Funding
No specific source of funding is associated with this work.
Author information
Authors and Affiliations
Contributions
ZA, MB, M-AP, HM, and Z-SR and O-RT contributed in the conception or design of the work and drafting of the manuscript. All authors confirmed the final version for submission.
Corresponding author
Ethics declarations
Competing interest
All authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Asemi, Z., Behnam, M., Pourattar, M.A. et al. Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms. Cell Mol Neurobiol 41, 1195–1201 (2021). https://doi.org/10.1007/s10571-020-00903-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-020-00903-5